All In Biotech

Drug Trial Radar · NCT00231738

Protective Effect of EPA on Cardiovascular Events

Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 18,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

18,000

Actual

Start

Nov 1996

Primary completion

Not stated

Study completion Nov 2004

Sponsor

Lead sponsor
Kobe UniversityIndustry
Sponsor type
Industry
Collaborators
Mochida Pharmaceutical Company, Ltd.
First posted
Oct 4, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to test the hypothesis that the long-term use of highly (\>98%) purified EPA, in addition to HMG-CoA reductase inhibitor (statin), would be more effective than statin alone in preventing cardiovascular events in Japanese patients with hypercholesterolemia.

Conditions

  • Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

Interventions

  • Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major coronary events (sudden cardiac death, fatal and nonfatal myocardial infarction, unstable angina pectoris including hospitalization for ischemic episodes,events of angioplasty/ stenting or coronary artery bypass grafting)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kobe University Graduate School of Medicine Cardiovascular and Respiratory Medicine Division, Department of Internal Medicine

    Kobe, Hyōgo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.